Targeting Type 1 Diabetes (Sponsored Content)

Since you're a subscriber to this Bloomberg podcast, we thought you'd be interested in a six episode sponsored podcast called targeting the toughest diseases produced by Vertex Pharmaceuticals and Bloomberg Media Studios. It explores the innovative tools, methods, and unique philosophy Vertex Pharmaceuticals is using to search for treatments for some of humanity's most challenging diseases. Here's a recent episode.

I'm so goal oriented. I'm always just charging ahead. Like, we're gonna get it done by any means possible.

Focused and fearless. That's the best way to describe Madison Carter. Those qualities have helped Madison break a lot of important stories as an award winning investigative reporter in Atlanta, Georgia. She's investigated white nationalists, political corruption, and the parole system. Those are stories that take a lot of guts to cover, and Madison has done it all without hesitation.

People will tell you, I go for everything. I say everything that needs to be said. Like, I have no fear. Like, I don't have a lot to lose. That

fearlessness comes from a dark place. It's

because of my diabetes. I'm like, I could die at any second.

Hi. I'm Jordan Gossepourre, a member of the University of Southern California's Center for Health Journalism. This is targeting the toughest diseases produced by Bloomberg Media Studios and Vertex Pharmaceuticals. In this series, we look at some of humanity's most challenging diseases and how Vertex, a Boston based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Today, we're targeting type one diabetes, a chronic disease that affects more than eight million people around the world, a number that's expected to increase rapidly. In

I don't think I ever had the opportunity to be a kid.

Since she was three years old, Madison's life has included a highly controlled diet, constantly measuring her blood sugar levels and insulin shots.